You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

lymphoid

Showing 1 - 25 of 3,711
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematopoietic Organs; Disorder Trial in Hong Kong (Total lymphoid irradiation)

Recruiting
  • Hematopoietic Organs; Disorder
  • Total lymphoid irradiation
  • Hong Kong, Hong Kong
    Hong Kong Children's Hospital
Oct 4, 2023

B-cell Lymphoid Malignancies Trial (ESG206)

Not yet recruiting
  • B-cell Lymphoid Malignancies
  • (no location specified)
Apr 10, 2023

Advanced Solid Tumor Trial in Bordeaux (MEDI5752)

Not yet recruiting
  • Advanced Solid Tumor
  • Bordeaux, France
    Institut Bergonie
May 24, 2023

Adult Soft Tissue Sarcoma, Non Small Cell Lung Cancer, Triple Negative Breast Cancer Trial in France (Ezabenlimab + BI907828)

Not yet recruiting
  • Adult Soft Tissue Sarcoma
  • +4 more
  • Ezabenlimab + BI907828
  • Bordeaux, France
  • +5 more
Oct 19, 2023

T-cell Lymphoma, CLL/SLL Trial in Birmingham (Tazemetostat, Acalabrutinib and Tazemetostat)

Not yet recruiting
  • T-cell Lymphoma
  • CLL/SLL
  • Birmingham, Alabama
    University of Alabama at Birmingham
Aug 11, 2023

The Lymphoid Tissue Pharmacology of Antiretroviral Drugs

Not yet recruiting
  • HIV Infection
  • Anti-HIV Agents
  • (no location specified)
Nov 4, 2022

Lymphoma, Non-Hodgkin Lymphoma, NHL Trial run by the National Cancer Institute (NCI) (Vysis LSI MYC Break Apart Rearrangement

Recruiting
  • Lymphoma
  • +4 more
  • Vysis LSI MYC Break Apart Rearrangement Probe Kit
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Immune Reconstitution After Allo-HSCT and Blinatumomab

Not yet recruiting
  • Leukemia, Lymphoid
  • (no location specified)
Oct 3, 2023

Lymphoma, Non-Hodgkin Trial (JNJ-87801493, JNJ-80948543, JNJ-75348780)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • (no location specified)
Nov 15, 2023

H19 in Acute Lymphoblastic Leukemia.

Not yet recruiting
  • Acute Lymphoid Leukemia
    • (no location specified)
    Jul 11, 2023

    Type 2 Innate Lymphoid Cells in Severe Pediatric Asthma

    Withdrawn
    • Severe Asthma
    • Biopsy
    • +2 more
    • Paris, France
      Hôpital Necker Enfants malades
    Nov 7, 2022

    Relapsed Lymphoid Malignancies, Refractory Lymphoid Malignancies Trial in Bentleigh (CN1, 0.5mg/kg and CN401, 400mg, CN1, 1mg/kg

    Terminated
    • Relapsed Lymphoid Malignancies
    • Refractory Lymphoid Malignancies
    • CN1, 0.5mg/kg and CN401, 400mg
    • +4 more
    • Bentleigh, Victoria, Australia
      Monash Health - Monash Medical Centre
    Oct 20, 2022

    Non Hodgkin Lymphoma, Hodgkin Lymphoma, Myeloma Trial in Tampa (CC-486, Duvelisib)

    Recruiting
    • Non Hodgkin Lymphoma
    • +3 more
    • Tampa, Florida
      Moffitt Cancer Center
    Jan 18, 2023

    B-cell Lymphoid Malignancies Trial (ESG206)

    Not yet recruiting
    • B-cell Lymphoid Malignancies
    • (no location specified)
    Aug 8, 2022

    Lymphoid Malignancies Trial in United States (AVM0703)

    Recruiting
    • Lymphoid Malignancies
    • Duarte, California
    • +6 more
    Nov 14, 2022

    Leukemia, Lymphoid Trial in Chengdu (blinatumomab)

    Recruiting
    • Leukemia, Lymphoid
    • Chengdu, Sichuan, China
      West China Hospital of Sichuan University
    Oct 27, 2023

    HIV Infection Trial in New York (Colonoscopy)

    Not yet recruiting
    • HIV Infection
    • Colonoscopy
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Dec 7, 2022

    Leukemia, Lymphoid Trial in Chengdu (blinatumomab)

    Not yet recruiting
    • Leukemia, Lymphoid
    • Chengdu, Sichuan, China
      West China Hospital of Sichuan University
    Oct 3, 2023

    Tumor, Plasma Cell, Lymphoma Trial in Toulouse (Comprehensive Geriatric Assessment)

    Recruiting
    • Neoplasm, Plasma Cell
    • Lymphoma
    • Comprehensive Geriatric Assessment
    • Toulouse, France
      University Hospital Toulouse
    Oct 12, 2022

    Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia Trial in Cleveland (Fully human anti CD19 CAR-T

    Recruiting
    • Non Hodgkin Lymphoma
    • +2 more
    • Fully human anti CD19 CAR-T Cell Dose
    • +2 more
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Oct 4, 2022

    B-Lymphoid Malignancies, Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia Trial in Houston (Fludarabine,

    Active, not recruiting
    • B-Lymphoid Malignancies
    • +3 more
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Aug 1, 2022

    Pediatric and Young Adult B-Cell Malignancies After Commercially

    Not yet recruiting
    • Lymphoid Leukemia
    • Questionnaire for patients receiving therapy
    • Palo Alto, California
      Stanford University
    May 9, 2023

    Breast Cancer, Hodgkin Lymphoma, Kidney Cancer Trial (Assessment tool IA3-CP with SDoH, Assessment tool IA3-CP without SDoH)

    Not yet recruiting
    • Breast Cancer
    • +9 more
    • Assessment tool IA3-CP with SDoH
    • Assessment tool IA3-CP without SDoH
    • (no location specified)
    May 22, 2023

    Acute Lymphoid Leukemia, Minimal Residual Disease, Gene Abnormality Trial in São Paulo (Prednisone, Vincristin, Daunorubicin)

    Recruiting
    • Acute Lymphoid Leukemia
    • +3 more
    • São Paulo, SP, Brazil
      Instituto do Cancer do Estado de Sao Paulo
    Jul 24, 2023

    Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia Refractory, B-cell Lymphoma Recurrent Trial in São Paulo

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • +5 more
    • São Paulo, Brazil
      Hospital Israelita Albert Einstein
    Jan 20, 2023